Clinical effect of AA-673 nasal spray in nasal allergy.

概要

論文の詳細を見る
AA-673 nasal spray (2.7 mg in six doses a day) was administered to 17 patients with nasal allergy in all seasons for 4 consecutive weeks. The clinical efficacy was rated as "moderate to marked improvement" in 47% and as "slight to marked improvement" in 82%. The clinical safety was rated as "no problem" in 94%. The general usefulness was considered "moderate to marked usefulness" in 71%. Subjective improvement: in 31 % of the patients sneezing attacks, in 29% nasal discharge and in 29% nasal obstruction were reduced. Objective improvement : in 55% of the patients eosinophiles in nasal discharge were reduced. The conditions of the nasal cavity were not always improved. Intranasal dry feeling was noted in one case. The authors consider that AA-673 nasal spray can be recommended for the treatment of nasal allergy.
耳鼻咽喉科臨床学会の論文